Name: Selective Cox-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential (en Inglés)
Price: 124.05 USD
Availability: InStock
Author: William Harvey Research Conference,Botting Jack H.,Vane John R.
ISBN: 9780792387299

portada Selective Cox-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential (en Inglés)

Selective Cox-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

William Harvey Research Conference,Botting Jack H.,Vane John R.

Idioma

Inglés

N° páginas

160

Encuadernación

Tapa Dura

ISBN13

9780792387299

N° edición

Selective Cox-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential (en Inglés)

William Harvey Research Conference,Botting Jack H.,Vane John R. (Autor) · Springer · Tapa Dura

Libro Nuevo Importado

Envío: 16 a 23 días háb.

$ 206.76$ 124.05

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 124.05

Llega entre el 14 Jul y el 27 Jul a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Selective Cox-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential (en Inglés)"

Preface. 1. Mechanism of Action of Anti-Inflammatory Drugs: An Overview; J.R. Vane, R.M. Botting. 2. The Structure of Human COX-2 and Selective Inhibitors; M.F. Browner. 3. Differential Inhibition of COX-1 and COX-2 by NSAIDs: A Summary of Results Obtained Using Various Test Systems; M. Pairet, et al. 4. COX-2 in Brain and Retina: Role in Neuronal Survival; N.G. Bazan, et al. 5. COX-2 and Apoptosis: NSAIDs as Effectors of Programmed Cell Death; D.L. Simmons, et al. 6. Inhibition of Intestinal Tumorigenesis via Selective Inhibition of COX-2; R.N. DuBois, et al. 7. Cyclooxygenase Enzymes in Human Vascular Disease; C. Patrono, et al. 8. Gastrointestinal Effects of NSAIDs; C.J. Hawkey. 9. Renal Side-Effects of NSAIDs: Role of COX-1 and COX-2; J.C. Frolich, D.O. Stichtenoth. 10. Aspirin-Induced Asthma and Cyclooxygenases; R.J. Gryglewski. 11. New Classification of Aspirin-like Drugs; H. Fenner. 12. New Highly Selective COX-2 Inhibitors; A.W. Ford-Hutchinson. 13. Specific COX-2 Inhibitors: From Bench to Bedside; P. Isakson, et al. 14. Meloxicam: Selective COX-2 Inhibition in Clinical Practice; D.E. Furst. Index.